Lithium Ion

Lithium Ion

SCHEMBL259977

O=C([O-])Cn1cc2c3c(cccc31)CC(=O)N2.[Li+]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 2/20 0.44
AHR P35869 2/20 0.39
PDK2 Q15119 1/20 0.39
CRBN Q96SW2 4/20 0.34
PGR P06401 2/20 0.33
TDP2 O95551 4/20 0.32
HTR1A P08908 1/20 0.32
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR7 P34969 1/20 0.32
DRD3 P35462 1/20 0.32
HTR2B P41595 1/20 0.32
CASP3 P42574 1/20 0.31
CASP7 P55210 1/20 0.31
CASP9 P55211 1/20 0.31
CASP6 P55212 1/20 0.31
CASP8 Q14790 1/20 0.31
MAP3K14 Q99558 1/20 0.31
GRIA1 P42261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL261118 0.94 CALCRL (0.49) CALCRLAHRPDK2CRBNPGR
SCHEMBL261415 0.87 CALCRL (0.46) CALCRLAHRPDK2
SCHEMBL12965351 0.83 GAA (0.43) CALCRLAHRPDK2GAA
SCHEMBL261355 0.81 ALDH1A1 (0.45) CALCRLDRD2
SCHEMBL261425 0.81 CALCRL (0.51) CALCRLAHRPDK2GRIN2B
Lithium Ion SCHEMBL260522 0.78 CALCRL (0.40) CALCRLCRBNGAAGRIN2B
SCHEMBL261471 0.78 AHR (0.41) CALCRLAHRPDK2PGRTDP2
SCHEMBL12965352 0.77 CALCRL (0.48) CALCRLAHRPDK2GAA
Lithium Ion SCHEMBL260221 0.76 AHR (0.40) CALCRLAHR
SCHEMBL2054600 0.75 ALDH1A1 (0.47) CALCRLDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163752-B2 Tricyclic anilide heterocyclic CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-04-24 US disclosed
US-8133891-B2 Tricyclic anilide spirolactam CGRP receptor antagonists Merck, Sharp & Dohme Corp. (US) 2012-03-13 US disclosed
US-7968540-B2 Spirohydantoin tricyclic CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-06-28 US disclosed
US-7947677-B2 Spirolactam tricyclic CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-05-24 US disclosed